SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Frankfurt
Börse Börse Frankfurt
ISIN AU000000CSL8
EUR
  • CSL
    Börse Börse Frankfurt
    ISIN AU000000CSL8 WKN: 890952
    Symbol CSJ
    EUR
  • CSL LTD
    Börse Börse Frankfurt
    WKN 890952
    Symbol CSL
    EUR
  • CSL LTD
    Börse Börse Düsseldorf
    Symbol CSJ
    EUR
  • CSL LTD
    Börse Börse Stuttgart
    Symbol CSJ
    EUR
  • CSL LTD
    Börse Börse München
    Symbol CSJ
    EUR
  • CSL LTD
    Börse Quotrix System der Börse Düsseldorf
    Symbol CSJ
    EUR
  • CSL LTD
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol CSJ
    EUR
  • CSL LTD
    Börse Gettex System der Börse München
    Symbol CSJ
    EUR
  • CSL LTD
    Börse Börse Berlin
    Symbol CSJ
    EUR
  • CSL Limited
    Börse Amerikanscher Freiverkehr OTC oder "Pink Sheets"
    USD
  • CSL
    Börse YHD
    ISIN AU000000CSL8 WKN: 890952
    Symbol CSJ
    USD
  • EUR
  • MXN
  • AUD
  • USD
  • USD
ISIN AU000000CSL8
WKN 890952
Symbol CSJ
Währung EUR
Börse Börse Frankfurt Zeitzone: America/Mexico_City
Mitarbeiter 30.000

131 News & Informationen zur CSL LTD Aktie

  • FDA Approves New BERINERT® (C1 Esterase Inhibitor, Human (Intravenous)) Administration Kit For Increased Patient Convenience
    thestreet.com

    FDA Approves New BERINERT® (C1 Esterase Inhibitor, Human (Intravenous)) Administration Kit For Increased Patient Convenience

    KING OF PRUSSIA, Pa., Aug. 3, 2021 /PRNewswire/ —   CSL Behring, a global biotherapeutics leader received U.S. Food and Drug Administration (FDA) approval for

  • ASX 200 shares to shift earnings growth up a gear in FY22 – Expert
    fool.com.au

    ASX 200 shares to shift earnings growth up a gear in FY22 – Expert

    This fund manager is expecting an acceleration in earnings in FY22. Take a look at what ASX 200 shares it's holding in anticipation.

  • Seqirus Presents New Safety Data Demonstrating Safety of Cell-Based Seasonal Influenza Vaccine on Pregnancy Outcomes
    prnewswire.com

    Seqirus Presents New Safety Data Demonstrating Safety of Cell-Based Seasonal Influenza Vaccine on Pregnancy Outcomes

    /PRNewswire/ — Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), presented findings from a new observational safety…

  • Seqirus Presents New Safety Data Demonstrating Safety Of Cell-Based Seasonal Influenza Vaccine On Pregnancy Outcomes
    thestreet.com

    Seqirus Presents New Safety Data Demonstrating Safety Of Cell-Based Seasonal Influenza Vaccine On Pregnancy Outcomes

    SUMMIT, N.J., July 30, 2021 /PRNewswire/ — Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), presented findings from a

  • ScoPo’s Powerplays: Solid earnings on health stocks all round, but price action stays with larger caps
    stockhead.com.au

    ScoPo’s Powerplays: Solid earnings on health stocks all round, but price action stays with larger caps

    Stock on Morgans’ ASX health stocks coverage list have mostly done well, but their share prices are disappointingly not responding to the results.

  • ASX Update: Falling US futures subdue market
    themarketherald.com.au

  • ASX Close: Ore miners cash in on boomtime prices
    themarketherald.com.au

  • Global $9.5 Billion Influenza Vaccines Market to 2027
    prnewswire.com

    Global $9.5 Billion Influenza Vaccines Market to 2027

    /PRNewswire/ — The “Global Influenza Vaccines Market, Persons Vaccinated, Impact of COVID-19, Company Analysis, Size, Share, Growth, Trends, Major Deals -…

  • ASX Close: Miners dig path to new heights
    themarketherald.com.au

  • ASX Update: BHP, Rio Tinto propel market to fresh high
    themarketherald.com.au

  • ASX rises on commodity rally and BHP record, Bitcoin rebounds
    abc.net.au

    ASX rises on commodity rally and BHP record, Bitcoin rebounds

    Mining stocks led the Australian share market higher, with BHP setting fresh intraday and closing highs. Bitcoin continues to rise sharply, rebounding from recent steep falls.

  • Athenex Announces Additional Licensing Agreements for Tirbanibulin
    asiaone.com

    Athenex Announces Additional Licensing Agreements for Tirbanibulin

    Athenex Announces Additional Licensing Agreements for Tirbanibulin
    Athenex expands its international commercial partnerships for tirbanibulin in Australia, New Zealand and Canada

    GlobeNewswire

    July 26, 2021

    BUFFALO, N.Y., July 26, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for…

  • Why the CSL (ASX:CSL) share price is up 5% in a week
    fool.com.au

    Why the CSL (ASX:CSL) share price is up 5% in a week

    The CSL Ltd (ASX: CSL) share price has bounced higher in the last week. What's next for CSL and the plasma collection industry?

  • ASX 200 Weekly Wrap: Just like that… ASX back to record highs
    fool.com.au

    ASX 200 Weekly Wrap: Just like that… ASX back to record highs

    Here on our ASX 200 Foolish Weekly Wrap, we look at the things that moved the S&P/ASX 200 Index and the broader share market last week!

  • ASX 200 morning report – CWN, SGR & SLR shares in focus
    raskmedia.com.au

    ASX 200 morning report – CWN, SGR & SLR shares in focus

    The S&P/ASX 200 (INDEXASX:XJO) managed to deliver another positive week, despite finishing just 0.1% higher on Friday.

  • Market hits a record despite COVID 'national emergency'
    smallcaps.com.au

    Market hits a record despite COVID 'national emergency'

    Sydney might well be a “national emergency’’ of COVID-19 cases but that hasn’t stopped the Australian share market from once again setting a new record high close on Friday.

  • Carlisle (CSL) Q2 Earnings and Revenues Top Estimates, Up Y/Y
    investing.com

    Carlisle (CSL) Q2 Earnings and Revenues Top Estimates, Up Y/Y

    Stocks Analysis by Zacks Investment Research covering: 3M Company, ITT Inc, Carlisle Companies Incorporated, Griffon Corporation. Read Zacks Investment Research's latest article on Investing.com

  • ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips
    stockhead.com.au

    ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips

    ASX Healthcare stocks have outperformed the market during the week, up 5%, compared to the broader market which rose by 0.52%.

  • Top 5 Rubber Stocks to Buy in 2021
    investmentu.com

    Top 5 Rubber Stocks to Buy in 2021

    Here are some of the best rubber stocks to buy right now. Increased demand and supply chain disruptions are putting pressure rubber prices.

  • Australian shares end at record high on healthcare, tech boost
    economictimes.indiatimes.com

    Australian shares end at record high on healthcare, tech boost

    The S&P/ASX 200 index settled up 0.1% at 7,394.4, after falling as much as 0.2% during the session. For the week, it gained 0.6%, recovering from sharp losses recorded earlier.

  • Australian shares end at record high on healthcare, tech boost
    marketscreener.com

    Australian shares end at record high on healthcare, tech boost

    Australian shares closed at a record
    high after a choppy afternoon trade on Friday, as gains in
    healthcare and tech stocks slightly outweighed losses in
    financial and energy firms.
    The… | July 23, 2021

  • ASX ends week on high with closing record
    businessnews.com.au

    ASX ends week on high with closing record

    Investors have extended an ASX record as they look beyond the coronavirus lockdowns plaguing about half of Australia's population.

  • 3 ASX 50 shares named as buys
    fool.com.au

    3 ASX 50 shares named as buys

    Xero Limited (ASX:XRO) and these ASX 50 shares are highly rated. Here's what you need to know about these shares…

  • ASX Close: Record finish caps winning week
    themarketherald.com.au

  • ASX Update: Stocks climb wall of worry towards third gain
    themarketherald.com.au

  • TGA approves Pfizer vaccine for kids aged 12-15 years old
    fool.com.au

    TGA approves Pfizer vaccine for kids aged 12-15 years old

    The Pfizer Inc (NYSE: PFE) COVID-19 vaccine has been approved for use in children aged 12-15 years in Australia.

  • Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period - by PMI
    globenewswire.com

    Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI

    Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…

  • Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period - by PMI
    globenewswire.com

    Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI

    Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…

  • Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period - by PMI
    globenewswire.com

    Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI

    Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…

  • Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period - by PMI
    globenewswire.com

    Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI

    Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…

  • Lithium miners, Lynas drive Australia shares to best day in a month
    economictimes.indiatimes.com

    Lithium miners, Lynas drive Australia shares to best day in a month

    The S&P/ASX 200 index closed 1.1% higher at 7,386.4 in its second straight session of gains, shrugging off worries over extended lockdowns in major states of the country.

  • 2 blue chip ASX 200 shares rated as buys
    fool.com.au

    2 blue chip ASX 200 shares rated as buys

    CSL Limited (ASX:CSL) and this blue chip ASX 200 share have been given buy ratings. Here's why analysts rate them highly…

  • ASX Close: Record close as global rebound accelerates
    themarketherald.com.au

  • ASX Update: Miners drive rebound into second day
    themarketherald.com.au

  • What is the outlook for the CSL (ASX:CSL) share price?
    fool.com.au

    What is the outlook for the CSL (ASX:CSL) share price?

    After a rather lacklustre 2021 so far, where is the CSL Limited (ASX: CSL) share price heading next? Here are some predictions….

  • ASX Close: Market rebounds, but correction talk lingers
    themarketherald.com.au

  • Here’s why the Cochlear (ASX:COH) share price is up 30% so far in 2021
    fool.com.au

    Here’s why the Cochlear (ASX:COH) share price is up 30% so far in 2021

    The Cochlear Ltd (ASX: COH) share price has been a solid performer amongst healthcare shares, rallying back to pre-COVID levels.

  • ASX 200 morning report – JBH, BHP & OSH shares in focus
    raskmedia.com.au

    ASX 200 morning report – JBH, BHP & OSH shares in focus

    Growing global outbreaks of the Delta strain have shaken markets but the S&P/ASX 200 (ASX: XJO) finished just 0.5% lower on Tuesday.

  • Lockdown uncertainty weighs down ASX
    businessnews.com.au

    Lockdown uncertainty weighs down ASX

    Australian shares ended lower for a second straight session as the growing uncertainty due to widening coronavirus lockdowns kept investors nervous.

  • ASX Close: Jittery market ends at four-week low
    themarketherald.com.au

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Entdecke die 6 ETFs in denen CSL LTD am höchsten gewichtet ist Insgesamt in 19 ETFs enthalten

Dir gefallen die Informationen zu CSL LTD?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu CSL LTD?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu CSL LTD?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu CSL LTD?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect